Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001736730-25-000023
Filing Date
2025-03-27
Accepted
2025-03-27 16:19:52
Documents
5
Effectiveness Date
2025-03-27

Document Format Files

Seq Description Document Type Size
1 S-8 a20250327forms-8.htm S-8 56045
2 EX-FILING FEES a20250327forms-8xexhibit107.htm EX-FILING FEES 19585
3 EX-5.1 a20250327forms-8xexhibit51.htm EX-5.1 8017
4 EX-23.1 a20250327forms-8xexhibit231.htm EX-23.1 2342
5 screenshot2025-03x19124256.jpg GRAPHIC 8611
  Complete submission text file 0001736730-25-000023.txt   99090
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286172 | Film No.: 25779569
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)